Curcumin: From ancient medicine to current clinical trials

Cellular and Molecular Life Sciences

Volumn 65, Issue 11, 2008, Pages 1631-1652

  Hatcher, H ^a   Planalp, R ^b   Cho, J ^b   Torti, F M ^a   Torti, S V ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Univ of New Hampshire   (United States)

Author keywords

Angiogenesis; Anti tumor; Anticancer; Antioxidant; Curcumin; Inflammation

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BIOPERINE; CAMPTOTHECIN; CELECOXIB; CISPLATIN; CURCUMIN; DAUNORUBICIN; DOXORUBICIN; GEMCITABINE; MELPHALAN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PACLITAXEL; PHENYLBUTAZONE; PIPERINE; SILIBININ; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CARCINOGENESIS; CLINICAL TRIAL; CURCUMA LONGA; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG INHIBITION; DRUG SAFETY; DRUG STABILITY; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; CURCUMA; CURCUMIN; FREE RADICAL SCAVENGERS; HUMANS; IRON; NEOPLASMS; NF-KAPPA B; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

CURCUMA LONGA;

EID: 44749093175     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-7452-4     Document Type: Review

References (228)

1. Köhler, F. E. (1887) Köhler's Medizinal-Pflanzen in naturgetreuen Abbildungen mit kurz erläuterndem Texte: Atlas zur Pharmacopoea germanica, Gera-Untermhaus. Gera.
2. Ammon, H. and Wahl, M. A. (1991) Pharmacology of Curcuma longa. Planta Med. 57, 1-7.
3. Aggarwal, B. B., Sundaram, C., Malani, N. and Ichikawa, H. (2007) Curcumin: The Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75.
4. Thakur, R., Puri, H. S. and Husain, A. (1989) Major medicinal plants of India, Central Institute of Medicinal and Aromatic Plants, Lucknow.
5. MacGregor, H. (2006) Out of the spice box, into the lab: Turmeric, an Indian staple, has long had medicinal uses. Now the West is taking notice. In: Los Angeles Times, Los Angeles, CA.
6. Pandeya, N. (2005) Old wives' tales: Modern miracles. Trees Life J. 1.
7. Tilak, J., Banerjee, M., Mohan, H. and Devasagayam, T. P. A. (2004) Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytother. Res. 18, 798-804.
8. Shishodia, S., Sethi, G. and Aggarwal, B. B. (2005) Curcumin: Getting back to the roots. Ann. N. Y. Acad. Sci. 1056, 206-217.
9. Huang, T., Lee, S. C. and Lin, J. K. (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 88, 5292-5296.
10. Lin, J. and Shih, C. A. (1994) Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis 15, 1717-1721.
11. Brouet, I. and Ohshima, H. (1994) Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206, 533-540.
12. Sreejayan, R. M. (1997) Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 49, 105-107.
13. Joe, B. and Lokesh, B. R (1994) Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224, 255-263.
14. Abe, Y., Hashimoto, S. and Horie, T. (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 39, 41-47.
15. Jefremov, V., Zilmer, M., Zilmer, K., Bogdanovic, N. and Karelson, E. (2007) Antioxidative effects of plant polyphenols: From protection of G protein signaling to prevention of age-related pathologies. Ann. N.Y. Acad. Sci. 1095, 449-457.
16. Reddy, A. C. and Lokesh, B. R. (1992) Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol. Cell. Biochem. 111, 117-124.
17. Sreejayan and Rao, M. N. (1994) Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46, 1013-1016.
18. Srimal, R. and Dhawan, B. N. (1973) Pharmacology of diferuloylmethane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25, 447-452.
19. Reddy, A. and Lokesh, B. R. (1994) Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann. Nutr. Metab. 38, 349-358.
20. Venkatesan, N. and Chandrakasan, G. (1995) Modulation of cyclophosphamide-induced early lung injury by curcumin, and inflammatory antioxidant. Mol. Cell. Biochem. 142, 79-87.
21. Huang, M., Lysz, T., Ferraro, T., Abidi, T. F., Laskin, J. D. and Conney, A. H. (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51, 813-819.
22. Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., Dicato, M. and Diederich, M. (2005) Chemopreventive and therapeutic effect of curcumin. Cancer Lett. 223, 181-190.
23. Maheshwari, R., Singh, A. K., Gaddipati, J. and Srimal, R. C. (2006) Multiple biological activities of curcumin: A short review. Life Sci. 78, 2081-2087.
24. Singh, S., Hu, X., Srivastava, S. K., Singh, M., Xia, H., Orchard, J. L. and Zaren, H. A. (1998) Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19, 1357-1360.
25. Deshpande, S., Ingle, A. D. and Maru, G. B. (1997) Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice. Cancer Lett. 118, 79-85.
26. Azuine, M. and Bhide, S. V. (1992) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer 17, 77-83.
27. Huang, M., Smart, R. C., Wong, C. Q. and Conney, A. H. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion inmouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48, 5941-5946.
28. Huang, M., Lou, Y. R., Ma, W., Newmark, H. L., Reuhl, K. R. and Conney, A. H. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54, 5841-5847.
29. Ikezaki, S., Nishikawa, A., Furukawa, F., Kudo, K., Nakamura, H., Tamura, K. and Mori, H. (2001) Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N'-nitro -N-nitrosoguanidine and sodium chloride in rats. Anticancer Res. 21, 3407-3411.
30. Ushida, J., Sugie, S., Kawabata, K., Pham, Q. V., Tanaka, T., Fujii, K., Takeuchi, H., Ito, Y. and Mori, H. (2000) Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J. Cancer Res. 91, 893-898.
31. Rao, C., Simi, B. and Reddy, B. S. (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219-2225.
32. Inano, H., Makoto, O., Inafuku, N., Kubota, M., Kamada, Y., Osawa, T., Kobayashi, H. and Wakabayashi, K. (1999) Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with grays. Carcinogenesis 20, 1011-1018.
33. Inano, H., Makoto, O., Inafuku, N., Kubota, M., Kamada, Y., Osawa, T., Kobayashi, H. and Wakabayashi, K. (2000) Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis 21, 1835-1841.
34. Sindhwani, P., Hampton, J. A., Baig, M. M., Keck, R. and Selman, S. H. (2001) Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J. Urol. 166, 1498-1501.
35. Garg, A., Buchholz, T. A. and Aggarwal, B. B. (2005) Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 7, 1630-1647.
36. Chirnomas, D., Taniguchi, T., de la Vega, M., Vaidya, A. P., Vasserman, M., Hartman, A. R., Kennedy, R., Foster, R., Mahoney, J., Seiden, M. V. and D'Andrea, A. D. (2006) Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther. 5, 952-961.
37. Deeb, D., Jiang, H., Gao, X., Divine, G., Dulchavasky, S. A. and Gautam, S. C. (2005) Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J. Exp. Ther. Oncol. 5, 81-91.
38. Jung, E. M., Lim, J. H., Lee, T. J., Park, J. W., Choi, K. S. and Kwon, T. K. (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26, 1905-1913.
39. Hour, T., Chen, J., Huang, C. Y., Guan, J. Y., Lu, S. H. and Pu, Y. S. (2002) Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51, 211-218.
40. Chuang, S. E., Yeh, P. Y., Lu, Y. S., Lai, G. M., Liao, C. M., Gao, M. and Cheng, A. L. (2002) Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem. Pharmacol. 63, 1709-1716.
41. Harbottle, A., Daly, A. K., Atherton, K. and Campbell, F. C. (2001) Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance. Int. J. Cancer 92, 777-783.
42. Verma, S. P., Goldin, B. R. and Lin, P. S. (1998) The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ. Health Perspect 106, 807-812.
43. Bharti, A., Donato, N, Singh, S. and Aggarwal, B. B. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062.
44. Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D. and Anto, R. J. (2005) Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J. Biol. Chem. 280, 6301-6308.
45. Notarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M. and D'Alessandro, N. (2005) Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-κB activation levels and in IAP gene expression. Cancer Lett. 224, 53-65.
46. Anuchapreeda, S., Leechanachai, P., Smith, M. M., Ambudkar, S. V. and Limtrakul, P. N. (2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64, 573-582.
47. Limtrakul, P., Anuchapreeda, S. and Buddhasukh, D. (2004) Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13.
48. Tang, X. Q., Bi, H., Feng, J. Q. and Cao, J. G. (2005) Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol. Sin. 26, 1009-1016.
49. Piwocka, K., Bielak-Mijewska, A. and Sikora, E. (2002) Curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells. Ann. N. Y. Acad. Sci. 973, 250-254.
50. Li, M., Zhang, Z., Hill, D. L., Wang, H. and Zhang, R. (2007) Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 67, 1988-1996.
51. Jagetia, G. C. (2007) Radioprotection and radiosensitization by curcumin. Adv. Exp. Med. Biol. 595, 301-320.
52. Chendil, D., Ranga, R. S, Meigooni, D., Sathishkumar, S. and Ahmed, M. M. (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23, 1599-1607.
53. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934.
54. Arbiser, J., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M. T., Fisher, C., Flynn, E. and Byers, H. R. (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 4, 376-383.
55. Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B. and Fini, M. E. (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem. 275, 10405-10412.
56. Gururaj, A., Belakavadi, M., Venkatesh, D. A., Marme, D. and Salimath, B. P. (2002) Molecular mechanisms of antiangiogenic effect of curcumin. Biochem. Biophys. Res. Commun. 297, 934-942.
57. Bhandarkar, S. S. and Arbiser, J. L. (2007) Curcumin as an inhibitor of angiogenesis. Adv. Exp. Med. Biol. 595, 185-195.
58. Thaloor, D., Singh, A. K., Sidhu, G. S., Prasad, P. V., Kleinman, H. K. and Maheshwari, R. K. (1998) Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ. 9, 305-312.
59. Santibáñez, J., Quintanilla, M. and Martínez, J. (2000) Genistein and curcumin block TGF-beta 1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes. Nutr. Cancer 37, 49-54.
60. Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J. Clin. Invest. 103, 1237-1241.
61. Lin, L. I., Ke, Y. F., Ko, Y. C. and Lin, J. K. (1998) Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55, 349-353.
62. Menon, L. G., Kuttan, R. and Kuttan, G. (1995) Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95, 221-225.
63. Menon, L. G., Kuttan, R. and Kuttan, G. (1999) Antimetastatic activity of curcumin and catechin. Cancer Lett. 141, 159-165.
64. Siebenlist, U., Franzoso, G. and Brown, K. (1994) Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10, 405-455.
65. Baeuerle, P. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
66. Barnes, P. and Karin, M. (1997) Nuclear factor-kappaB - A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071.
67. Amit, S. and Ben-Neriah, Y. (2003) NF-kappaB activation in cancer: A challenge for ubiquitination-and proteasome-based therapeutic approach. Semin Cancer Biol. 13, 15-28.
68. Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A. and Sartor, R. B. (1999) Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163, 3474-3483.
69. Singh, S. and Aggarwal, B. B. (1995) Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J. Biol. Chem. 270, 24995-25000.
70. Bachmeier, B., Nerlich, A. G., Iancu, C. M., Cilli, M., Schleicher, E., Vene, R., Dell'Eva, R., Jochum, M., Albini, A. and Pfeffer, U. (2007) The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol. Biochem. 19, 137-152.
71. Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S. and Aggarwal, B. B. (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 69, 195-206.
72. Kossakowska, A., Huchcroft, S. A., Urbanski, S. J. and Edwards, D. R. (1996) Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br. J. Cancer 73, 1401-1408.
73. Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A. L., Keski-Oja, J. and Saarialho-Kere, U. K. (1999) Expression of collagenases-1 and-3 and their inhibitors TIMP-1 and-3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer 80, 733-743.
74. Murray, G., Duncan, M. E., O'Neil, P., Melvin, W. T. and Fothergill, J. E. (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2, 461-462.
75. Tetu, B., Brisson, J., Lapointe, H. and Bernard, P. (1998) Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer. Hum. Pathol. 29, 979-985.
76. Kelloff, G., Crowell, J. A., Steele, V. E., Lubet, R. A., Boone, C. W., Malone, W. A., Hawk, E. T., Lieberman, R., Lawrence, J. A., Kopelovich, L., Ali, I., Viner, J. L. and Sigman, C. C. (1999) Progress in cancer chemoprevention. Ann. N. Y. Acad. Sci. 889, 1-13.
77. Thangapazham, R., Sharma, A. and Maheshwari, R. K. (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8, E443-449.
78. Mann, J. and DuBois, R. N. (2004) Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 10, 145-152.
79. Prescott, S. (2000) Is cyclooxygenase-2 the alpha and the omega in cancer? J. Clin. Invest. 105, 1511-1513.
80. Ammon, H. and Wahl, M. A. (1991) Pharmacology of Curcuma longa. Planta Med. 57, 1-7.
81. Kargman, S., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A. and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res. 55, 2556-2559.
82. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F. and Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809.
83. Kawamori, T., Rao, C. V, Seibert, K. and Reddy, B. S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409-412.
84. Zhang, F., Altorki, N. K., Mestre, J. R., Subbaramaiah, K. and Dannenberg, A. J. (1999) Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20, 445-451.
85. Plummer, S., Holloway, K. A., Manson, M. M., Munks, R. J., Kaptein, A., Farrow, S. and Howells, L. (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013-6020.
86. Vane, J. and Botting, RM. (1995) New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44, 1-10.
87. Eberhart, C. and Dubois, R. N. (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109, 285-301.
88. Baldin, V., Lukas, J, Marcote, M. J, Pagano, M. and Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
89. Mukhopadhyay, A., Banerjee, S, Stafford, L. J, Xia, C, Liu, L. and Aggarwal, B. B. (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21, 8852-8861.
90. Park, M. J., Kim, E. H., Park, I. C., Lee, H. C., Woo, S. H., Lee, J. Y., Hong, Y. J., Rhee, C. H., Choi, S. H., Shim, B. S., Lee, S. H. and Hong, S. I. (2002) Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int. J. Oncol. 21, 379-383.
91. Cheng, Y., Ping, J. and Xu, L. M. (2007) Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chinese Med. J. 120, 794-801.
92. Sandur, S. K., Ichikawa, H., Pandey, M. K., Kunnumakkara, A. B., Sung, B., Sethi, G. and Aggarwal, B. B. (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med. 43, 568-580.
93. Roy, M., Chakraborty, S., Siddiqi, M. and Bhattacharya, R. K (2002) Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac. J. Cancer Prev. 3, 61-67.
94. Deeb, D., Jiang, H., Gao, X., Al-Holou, S., Danyluk, A. L., Dulchavsky, S. A. and Gautam, S. C. (2007) Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6- heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J. Pharmacol. Exp. Ther. 321, 616-625.
95. Anto, R., Mukhopadhyay, A., Denning, D. and Aggarwal, B. B. (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150.
96. Shishodia, S., Amin, H. M, Lai, R. and Aggarwal, B. B. (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 70, 700-713.
97. Xu, Y., Pindolia, K., Janakiraman, N., Chapman, R. and Gautam, S. (1998) Curcumin inhibits IL-1alpha and TNF-alpha induction of AP-1 and NFκB DNA-binding activity in bone marrow stromal cells. Hematopathol. Mol. Hematol. 11, 49-62.
98. Hidaka, H., Ishiko, T., Furuhashi, T., Kamohara, H., Suzuki, S., Miyazaki, M., Ikeda, O., Mita, S., Setoguchi, T. and Ogawa, M. (2002) Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95, 1206-1214.
99. Cho, J. W., Lee, K. S. and Kim, C. W. (2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med. 19, 469-474.
100. Gao, X., Kuo, J., Jiang, H., Deeb, D., Liu, Y., Divine, G., Chapman, R. A., Dulchavsky, S. A. and Gautam, S. C. (2004) Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem. Pharmacol. 68, 51-61.
101. Bhattacharyya, S., Mandal, D., Sen, G. S., Pal, S., Banerjee, S., Lahiry, L., Finke, J. H., Tannenbaum, C. S., Das, T. and Sa, G. (2007) Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: Protection by curcumin. Cancer Res. 67, 362-370.
102. Yamaguchi, H. and Wang, H. G. (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20, 7779-7786.
103. Alessi, D., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr. Biol. 7, 261-269.
104. Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R., Reese, C. B., McCormick, F., Tempst, P., Coadwell, J. and Hawkins, P. T. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 673-674.
105. Woo, J., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., Bae, J. H., Min, D. S., Chang, J. S., Jeong, Y. J., Lee, Y. H., Park, J. W. and Kwon, T. K. (2003) Molecular mechanisms of curcumin-induced cytotoxicity: Induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24, 1199-1208.
106. Sarkar, F. and Li, Y. (2004) Cell signaling pathways altered by natural chemopreventive agents. Mutat. Res. 555, 53-64.
107. Jee, S., Shen, S. C., Tseng, C. R., Chiu, H. C. and Kuo, M. L. (1998) Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Invest. Dermatol. 11, 656-661.
108. Jiang, M., Yang-Yen, H. F., Lin, J. K. and Yen, J. J. (1996) Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 13, 609.
109. Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T. and Sa, G. (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 512, 334-340.
110. Choudhuri, T., Pal, S., Das, T. and Sa, G. (2005) Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280, 20059-20068.
111. Chen, Y., Kuo, T. C., Lin-Shiau, S. Y. and Lin, J. K. (1996) Induction of HSP70 gene expression by modulation of Ca(12) ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol. Carcinogenesis 17, 224-234.
112. Kato, K., Ito, H., Kamei, K. and Iwamoto, I. (1998) Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. Cell Stress Chaperones 3, 152-160.
113. Han, S.-S., Chung, S.-T, Robertson, D. A, Ranjan, D. and Bondada, S. (1999) Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53. Clin. Immunol. 93, 152-161.
114. Bush, J., Cheung, K.-J. J. and Li, G. (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 271, 305-314.
115. Prestera, T. and Talalay, P. (1995) Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA 92, 8965-8969.
116. Susan, M. and Rao, M. N. (1992) Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung 42, 962-964.
117. Dinkova-Kostova, A. T. and Talalay, P. (1999) Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20, 911-914.
118. Scapagnini, G., Colombrita, C, Amadio, M, D'Agata, V, Arcelli, E, Sapienza, M, Quattrone, A. and Calabrese, V. (2006) Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal. 8, 395-403.
119. Balogun, E., Hoque, M., Gong, P., Killeen, E., Green, C. J., Foresti, R., Alam, J. and Motterlini, R. (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371, 887-895.
120. Ciolino, H. P., Daschner, P. J., Wang, T. T. and Yeh, G. C. (1998) Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56, 197-206.
121. Dickinson, D., Iles, K. E., Zhang, H., Blank, V. and Forman, H. J. (2003) Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J. 17, 473-475.
122. Dickinson, D., Iles, K. E, Wigley, A. F. and Forman, H. J. (2004) Analysis of transcription factor remodeling in Phase II gene expression with curcumin. Methods Enzymol. 302-318.
123. Korutla, L., Cheung, J. Y., Mendelsohn, J. and Kumar, R. (1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16, 1741-1745.
124. Korutla, L. and Kumar, R. (1994) Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta 1224, 597-600.
125. Hong, R. L., Spohn, W. H. and Hung, M. C. (1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin. Cancer Res. 5, 1884-1891.
126. Yang, X., Thomas, D. P., Zhang, X., Culver, B. W., Alexander, B. M., Murdoch, W. J., Rao, M. N., Tulis, D. A., Ren, J. and Sreejayan, N. (2006) Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 26, 85-90.
127. Choi, H., Chun, Y. S., Kim, S. W., Kim, M. S. and Park, J. W. (2006) Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition. Mol. Pharmacol. 70, 1664-1671.
128. Xia, Y., Jin, L., Zhang, B., Xue, H., Li, Q. and Xu, Y. (2007) The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sci 80, 2161-2169.
129. Kobayashi, T., Hashimoto, S. and Horie, T. (1997) Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem. Pharmacol. 54, 819-824.
130. Aggarwal, B. and Shishodia, S. (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421.
131. Zhong, Z., Wen, Z. and Darnell, J. E. Jr. (1994) Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98.
132. Aggarwal, B. B., Sethi, G., Ahn, K. S., Sandur, S. K., Pandey, M. K., Kunnumakkara, A. B., Sung, B. and Ichikawa, H. (2006) Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: Modern target but ancient solution. Ann. N. Y. Acad. Sci. 1091, 151-169.
133. Kim, D. J., Chan, K. S., Sano, S. and Digiovanni, J. (2007) Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol. Carcinog. 46, 725-731.
134. Zushi, S., Shinomura, Y., Kiyohara, T., Miyazaki, Y., Kondo, S., Sugimachi, M., Higashimoto, Y., Kanayama, S. and Matsuzawa, Y. (1998) STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int. J. Cancer 78, 326-330.
135. Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., Heller, R., Ellis, L. M., Karras, J., Bromberg, J., Pardoll, D., Jove, R. and Yu, H. (2002) Constitutive Stat3 activity upregulates VEGF expression and tumor angiogenesis. Oncogene 21, 2000-2008.
136. Bharti, A. C., Donato, N. and Aggarwal, B. B. (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 171, 3863-3871.
137. Chakravarti, N., Myers, J. N. and Aggarwal, B. B. (2006) Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int. J. Cancer 119, 1268-1275.
138. Seger, R. and Krebs, E. G. (1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
139. Rana, A., Gallo, K., Godowski, P., Hirai, S., Ohno, S., Zon, L., Kyriakis, J. M. and Avruch, J. (1996) The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J. Biol. Chem. 271, 19025-19028.
140. Salh, B., Assi, K., Templeman, V., Parhar, K., Owen, D., Gomez-Munoz, A. and Jacobson, K. (2003) Curcumin attenuates DNB-induced murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G235-243.
141. Chen, Y. R. and Tan, T. H. (1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173-178.
142. Dhandapani, K. M., Mahesh, V. B. and Brann, D. W. (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J. Neurochem. 102, 522-538.
143. Meyer, C. F., Wang, X., Chang, C., Templeton, D. and Tan, T. H. (1996) Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J. Biol. Chem. 271, 8971-8976.
144. Aggarwal, B., Kumar, A. and Bharti, AC (2003) Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 23, 363-398.
145. Ruby, A., Kuttan, G., Babu, K. D., Rajasekharan, K. N. and Kuttan, R. (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 94, 79-83.
146. Milobedzka, J., v. Kostanecki, S. and Lampe, V. (1910) Curcumin. Ber. Dtsch. Chem. Ges. 43, 2163-70.
147. Lampe, V. and Milobedzka, J. (1913) Curcumin. Ber. Dtsch. Chem. Ges. 46, 2235-2240.
148. Ramsewak, R. S., DeWitt, D. L. and Nair, M. G. (2000) Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7, 303-308.
149. Payton, F., Sandusky, P. and Alworth, W. L. (2007) NMR study of the solution structure of curcumin. J. Nat. Prod. 70, 143-146.
150. Bernabe-Pineda, M. , Ramirez-Silva, M. T. , Romero-Romo, M., Gonzadlez-Vergara, E. and Rojas-Hernandez, A. (2004) Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition. Spectrochim. Acta A Mol. Biomol. Spectrosc. 60, 1091-1097.
151. Tonnesen, H. H. and Karlsen, J. (1985) Studies on curcumin and curcuminoids. V. Alkaline Degradation of Curcumin. Z. Lebensm. Unters. Forsch. 180, 132-134.
152. Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, Y. S., Hsieh, C. Y. and Lin, J. K. (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15, 1867-1876.
153. Price, L. C. and Buescher, R. W. (1997) Kinetics of alkaline degradation of the food pigments curcumin and curcuminoids. J. Food Sci. 62, 267-269.
154. Tonnesen, H. H., Karlsen, J. and van Henegouwen, G. B. (1986) Studies on curcumin and curcuminoids VIII. Photochemical stability of curcumin. Z. Lebensm. Unters. Forsch. 183, 116-122.
155. Ireson, C., Orr, S., Jones, D. J., Verschoyle, R., Lim, C. K., Luo, J. L., Howells, L., Plummer, S., Jukes, R., Williams, M., Steward, W. P. and Gescher, A. (2001) Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61, 1058-1064.
156. Ireson, C. R., Jones, D. J., Orr, S., Coughtrie, M. W., Boocock, D. J., Williams, M. L., Farmer, P. B., Steward, W. P. and Gescher, A. J. (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11, 105-111.
157. Holder, G. M., Plummer, J. L. and Ryan, A. J. (1978) The metabolism and excretion of curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5- dione] in the rat. Xenobiotica 8, 761-768.
158. Jaruga, E., Salvioli, S., Dobrucki, J., Chrul, S., Bandorowicz- Pikuła, J., Sikora, E., Franceschi, C., Cossarizza, A. and Bartosz, G. (1998) Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett. 433, 287-293.
159. Jarugaa, E., Sokala, A., Chrulb, S. and Bartosza, G. (1998) Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp. Cell Res. 245, 303-312.
160. Li, L., Braiteh, F. S. and Kurzrock, R. (2005) Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322-1331.
161. Maiti, K., Mukherjee, K., Gantait, A., Saha, B. P. and Mukherjee, P. K. (2007) Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 330, 155-163.
162. Arezzini, B., Ferrali, M., Ferrari, E., Grandi, R., Monti, S. and Saladini, M. (2004) Glycosyl-curcuminoids as potential new chelating agents in iron overload chelation therapy. Eur. J. Inorg. Chem. 646-652.
163. Lin, L., Shi, Q., Nyarko, A. K., Bastow, K. F., Wu, C. C., Su, C. Y., Shih, C. C. and Lee, K. H. (2006) Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J. Med. Chem. 49, 3963-3972.
164. Ohtsu, H., Xiao, Z., Ishida, J., Nagai, M., Wang, H. K., Itokawa, H., Su, C. Y., Shih, C., Chiang, T., Chang, E., Lee, Y., Tsai, M. Y., Chang, C. and Lee, K. H. (2002) Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J. Med. Chem. 45, 5037-5042.
165. Adams, B. K., Ferstl, E. M., Davis, M. C., Herold, M., Kurtkaya, S., Camalier, R. F., Hollingshead, M. G., Kaur, G., Sausville, E. A., Rickles, F. R., Snyder, J. P., Liotta, D. C. and Shoji, M. (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg. Med. Chem. 12, 3871-3883.
166. Nakano, K., Nakayachi, T., Yasumoto, E., Morshed, S. R., Hashimoto, K., Kikuchi, H., Nishikawa, H., Sugiyama, K., Amano, O., Kawase, M. and Sakagami, H. (2004) Induction of apoptosis by beta-diketones in human tumor cells. Anticancer Res. 24, 711-717.
167. Benassi, R., Ferrari, E., Grandi, R., Lazzari, S. and Saladini, M. (2007) Synthesis and characterization of new beta-diketo derivatives with iron chelating ability. J. Inorg. Biochem. 101, 203-213.
168. Woo, H. B., Shin, W. S., Lee, S. and Ahn, C. M. (2005) Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity. Bioorg. Med. Chem. Lett. 15, 3782-3786.
169. Dinkova-Kostova, A. T. and Talalay, P. (1999) Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20, 911-914.
170. Mohammadi, K., Thompson, K. H., Patrick, B. O., Storr, T., Martins, C., Polishchuk, E., Yuen, V. G., McNeill, J. H. and Orvig, C. (2005) Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J. Inorg. Biochem. 99, 2217-2225.
171. Thompson, K. H., Bohmerle, K., Polishchuk, E., Martins, C., Toleikis, P., Tse, J., Yuen, V., McNeill, J. H. and Orvig, C. (2004) Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J. Inorg. Biochem. 98, 2063-2070.
172. Vajragupta, O., Boonchoong, P. and Berliner, L. J. (2004) Manganese complexes of curcumin analogues: Evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis. Free Radic. Res. 38, 303-314.
173. Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Matsumoto, K. and Watanabe, H. (2004) Evaluation of the nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivative. Biol. Pharm. Bull. 27, 170-173.
174. Bernabe-Pineda, M., Ramirez-Silva, M. T., Romero-Romo, M. A., Gonzalez-Vergara, E. and Rojas-Hernandez, A. (2004) Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water. Spectrochim. Acta A Mol. Biomol. Spectrosc. 60, 1105-1113.
175. Borsari, M., Ferrari, E., Grandi, R. and Saladini, M. (2002) Curcuminoids as potential new iron-chelating agents: Spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorg. Chim. Acta 328, 61-68.
176. Ahsan, H. and Hadi, SM. (1998) Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Lett. 124, 23-30.
177. Barik, A., Mishra, B., Kunwar, A., Kadam, R. M., Shen, L., Dutta, S., Padhye, S., Satpati, A. K., Zhang, H.-Y. and Indira Priyadarsini, K. (2007) Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur. J. Med. Chem. 42, 431-439.
178. Barik, A., Mishra, B., Shen, L., Mohan, H., Kadam, R. M., Dutta, S., Zhang, H. Y. and Priyadarsini, K. I. (2005) Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic. Biol. Med. 39, 811-822.
179. John, V. D. and Krishnankutty, K. (2005) Synthesis, characterization and antitumour activities of some synthetic curcuminoid analogues and their copper complexes. Transition Metal Chem. 30, 229-233.
180. Mehrotra, R. C., Bohra, R. and Gaur, D. P. (1978) Metal β-Diketonates and Allied Derivatives, Academic Press, London.
181. Kunchandy, E. and Rao, M. N. A. (1989) Effect of curcumin on hydroxyl radical generation through Fenton reaction. Int. J. Pharm. 57, 173-176.
182. Toennesen, H. H. and Greenhill, J. V. (1992) Studies on curcumin and curcuminoids. XXII: Curcumin as a reducing agent and as a radical scavenger. Int. J. Pharm. 87, 79-87.
183. Ahsan, H., Parveen, N., Khan, N. U. and Hadi, S. M. (1999) Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem. Biol. Interact. 121, 161-175.
184. 3+ on curcumin-induced chromosomal aberrations in CHO cells. Genet. Mol. Biol. 28, 161-164.
185. Patro, B. S., Rele, S., Chintalwar, G. J., Chattopadhyay, S., Adhikari, S. and Mukherjee, T. (2002) Protective activities of some phenolic 1,3-diketones against lipid peroxidation: Possible involvement of the 1,3-diketone moiety. ChemBio-Chem 3, 364-370.
186. Jovanovic, S., Boone, C. W., Steenken, S., Trinoga, M. and Kaskey, R. B. (2001) How curcumin works preferentially with water soluble antioxidants. J. Am. Chem. Soc. 123, 3064-3068.
187. Jovanovic, S. V., Steenken, S., Boone, C. W. and Simic, M. G. (1999) H-atom transfer is a preferred antioxidant mechanism of curcumin. J. Am. Chem. Soc. 121, 9677-9681.
188. Wright, J. S. (2002) Predicting the antioxidant activity of curcumin and curcuminoids. J. Mol. Struct. (Theochem) 591, 207-217.
189. Litwinienko, G. and Ingold, K. U. (2004) Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J. Org. Chem. 69, 5888-5896.
190. Litwinienko, G. and Ingold, K. U. (2007) Solvent effects on the rates and mechanisms of reaction of phenols with free radicals. Acc. Chem. Res. 40, 222-230.
191. Jiao, Y., Wilkinson, J. 4th, Pietsch, E. C., Buss, J. L., Wang, W., Planalp, R., Torti, F. M. and Torti, S. V. (2006) Iron chelation in the biological activity of curcumin. Free Radic. Biol. Med. 40, 1152-1160.
192. Torti, F. M. and Torti, S. V. (2002) Regulation of ferritin genes and protein. Blood 99, 3505-3516.
193. Lal, B., Kapoor, A. K., Asthana, O. P., Agrawal, P. K., Prasad, R., Kumar, P. and Srimal, R. C. (1999) Efficacy of curcumin in the management of chronic anterior uveitis. Phytother. Res. 13, 318-322.
194. Lal, B., Kapoor, A. K., Agrawal, P. K., Asthana, O. P. and Srimal, R. C. (2000) Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother. Res. 14, 443-447.
195. Satoskar, R., Shah, S. J. and Shenoy, S. G. (1986) Evaluation of antiinflammatory property of curcumin (diferuloylmethane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 651-654.
196. Kuttan, R., Sudheeran, P. C. and Josph, C. D. (1987) Turmeric and curcumin as topical agents in cancer therapy. Tumori 73, 29-31.
197. Dhillon, N., Wolff, R. A., Abbruzzese, J. L., Hong, D., Camacho, L., Li, L., Braiteh, F. and Kurzrock, R. (2006) Phase II clinical trial of curcumin in patients with advanced pancreatic cancer: 2006 ASCO Annual Meeting Proceedings. J. Clin. Oncol. 24, 14151.
198. Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L. and Brenner, D. E. (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern. Med. 6, 10.
199. Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., Pirmohamed, M., Gescher, A. J. and Steward, W. P. (2004) Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer Res. 10, 6847-6854.
200. Shankar, T., Shantha, N. V., Ramesh, H. P., Murthy, I. A. and Murthy, V. S. (1980) Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs and monkeys. Indian J. Exp. Biol. 18, 73-75.
201. Soni, K. and Kuttan, R. (1992) Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J. Physiol. Pharmacol. 36, 273-275.
202. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Ming-Shiang, W., Yu, H. S., Jee, S. H., Chen, G. S., Chen, T. M., Chen, C. A., Lai, M. K., Pu, Y. S., Pan, M. H., Wang, Y. J., Tsai, C. C. and Hsieh, C. Y. (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Res. 21, 2895-2900.
203. Sharma, R. A., McLelland, H. R., Hill, K. A., Ireson, C. R., Euden, S. A., Manson, M. M., Pirmohamed, M., Marnett, L. J., Gescher, A. J. and Steward, W. P. (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7, 1894-1900.
204. Plummer, S. M., Hill, K. A., Festing, M. F., Steward, W. P., Gescher, A. J. and Sharma, R. A. (2001) Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 10, 1295-1299.
205. Tohda, C., Nakayama, N., Hatanaka, F. and Komatsu, K. (2006) Comparison of anti-inflammatory activities of six Curcuma rhisomes: A possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. Evid. Based Complement Altern. Med. 3, 255-260.
206. Tayyem, R. F., Heath, D. D., Al-Delaimy, W. K. and Rock C. L. (2006) Curcumin content of turmeric and curry powders. Nutr. Cancer 55, 126-131.
207. Jayaprakasha, G. K., Jagan Mohan Rao, L. and Sakariah, K. K. (2002) Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J. Agric. Food Chem. 50, 3668-3672.
208. Garcea, G., Jones, D. J., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J. and Berry, D. P. (2004) Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br. J. Cancer 90, 1011-1015.
209. Joe, B. and Lokesh, B. R. (2000) Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol. Cell. Biochem. 203, 153-161.
210. South, E. H., Exon, J. H. and Hendrix, K. (1997) Dietary curcumin enhances antibody response in rats. Immunopharmacol. Immunotoxicol. 19, 105-119.
211. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A. and Cole, G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370-8377.
212. Ram, A., Das, M. and Ghosh, B. (2003) Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol. Pharm. Bull. 26, 1021-1024.
213. Reyes-Gordillo, K., Segovia, J., Shibayama, M., Vergara, P., Moreno, M. G. and Muriel, P. (2007) Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770, 989-996.
214. Chuang, S. E., Kuo, M. L., Hsu, C. H., Chen, C. R., Lin, J. K., Lai, G. M., Hsieh, C. Y. and Cheng, A. L. (2000) Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21, 331-5.
215. Corona-Rivera, A., Urbina-Cano, P., Bobadilla-Morales, L., Vargas-Lares, Jde J., Ramirez-Herrera, M. A., Mendoza-Magaua, M. L., Troyo-Sanroman. R., Diaz-Esquivel, P., Corona-Rivera, J. R. (2007) Protective in vivo effect of curcumin on copper genotoxicity evaluated by comet and micronucleus assays. J. Appl. Genet. 48, 389-396.
216. Manjunatha, H. and Srinivasan, K. (2007) Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats. Lipids 42, 1133-1142.
217. Farombi, E. O. and Ekor, M. (2006) Curcumin attenuates gentamicin-induced renal oxidative damage in rats. Food Chem. Toxicol. 44, 1443-1448.
218. Rasyid, A. and Lelo, A. (1999) The effect of curcumin and placebo on human gall-bladder function: An ultrasound study. Aliment. Pharmacol. Ther. 13, 245-249.
219. Sakano, K. and Kawanishi, S. (2002) Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch. Biochem. Biophys. 405, 223-230.
220. Yoshino, M., Haneda, M., Naruse, M., Htay, H. H., Tsubouchi, R., Qiao, S. L., Li, W. H., Murakami, K. and Yokochi, T. (2004) Prooxidant activity of curcumin: Copper-dependent formation of 8-hydroxy-2'-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol. In Vitro 18, 783-789.
221. Strasser, E. M., Wessner, B., Manhart, N. and Roth, E. (2005) The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells. Biochem. Pharmacol. 70, 552-559.
222. Urbina-Cano, P., Bobadilla-Morales, L., Ramirez-Herrera, M. A., Corona-Rivera, J. R., Mendoza-Magana, M. L., Troyo-Sanroman, R. and Corona-Rivera, A. (2006) DNA damage in mouse lymphocytes exposed to curcumin and copper. J. Appl. Genet. 47, 377-382.
223. Polasa, K., Naidu, A. N., Ravindranath, I. and Krishnaswamy, K. (2004) Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat. Res. 557, 203-213.
224. Nair, J., Strand, S., Frank, N., Knauft, J., Wesch, H., Galle, P. R. and Bartsch, H. (2005) Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: Enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 26, 1307-1315.
225. Frank, N., Knauft, J., Amelung, F., Nair, J., Wesch, H. and Bartsch, H. (2003) No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat. Res. 523-524, 127-135.
226. Moos, P. J., Edes, K., Mullally, J. E. and Fitzpatrick, F. A. (2004) Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25, 1611-1617.
227. Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y. Y. and Orlowski, R. Z. (2002) Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 62, 3868-3875.
228. Goel, A., Kunnumakkara, A. B. and Aggarwal, B. B. (2008) Curcumin as "Curecumin": From kitchen to clinic. Biochem. Pharmacol. 75, 787-809.